Health, Biopharma, & Health-Tech

May 28th, 2024 Stateline recently published an article featuring Rena Conti, Associate Professor of Markets, Public Policy, and Law, discussing...

In the ongoing battle against healthcare fraud, understanding the effectiveness of anti-fraud efforts is paramount. This Q&A, featuring Questrom Assistant...

April 28th, 2024 HFMA recently published an article featuring James Rebitzer, Professor of Markets, Public Policy, and Law, discussing the...

April 25th, 2024 Stat recently published an article co-authored by James Rebitzer, Professor in Markets, Public Policy, and Law, discussing...

MoneyGeek recently published a column featuring Roberta Clarke, Associate Professor Emerita in Marketing, discussing ways to find the best health...

March 1st, 2024 Boston Business Journal recently published an interview featuring Ned Rimer, Master Lecturer of Management and Organizations discussing...

American Academy of Pediatrics recently published a study co-led by Rena Conti, Associate Professor of Markets, Public Policy, and Law,...

Medicare has recently initiated negotiations to lower prescription drug costs, aiming to make medications more affordable for Americans. This program...

January 17th, 2024 Health Affairs recently published an article co-authored by Rena Conti, Associate Professor of Markets, Public Policy, and...

September 6, 2023  The New York Times recently published an article featuring James Rebitzer, Professor of Markets, Public Policy, and...

August 21, 2023  STAT recently published an article co-authored by James Rebitzer, Professor of Markets, Public Policy, and Law, on...

What are the benefits and limitations of Amazon's RxPass to Prime members? With Amazon’s new RxPass, Prime members can pay...

Harvard Business Review recently published an article by Tal Gross, Associate Professor, discussing ways insurers can benefit from copayments and...

Radio Health Journal recently published a segment featuring Rena Conti, Associate Professor of Markets, Public Policy, and Law, discussing her...

Lucia Ryll, fourth year medical student and Health Sector MBA candidate from Boston University, recently penned an op-ed for Medpage...

Medpage Today recently published an article co-authored by Rena Conti, Associate Professor of Markets, Public Policy, and Law, discussing how...

We often hear that “necessity is the mother of invention”, so it is no surprise that the Covid-19 pandemic –...

An unassuming duct tape-and-cardboard construction known as a Corsi-Rosenthal box – is playing an important part in the fight against...

Health Affairs Forefront recently published insight from their short series, “Prescription Drugs: Promoting Affordability and Innovation,” a conference hosted by...

BU Today’s podcast ‘Question of the Week’ recently interviewed Rena Conti, Associate Professor of Markets, Public Policy, & Law, on...

How has the COVID-19 pandemic shaped our ability to utilize Artificial Intelligence, and how have we adapted AI to respond...

Nature Human Behavior recently published a study co-researched by Chiara Longoni, Assistant Professor of Marketing, and Carey Morewedge, Professor of...

In regulating tobacco products, how should the FDA balance the goals of preventing youth consumption versus helping adult smokers quit?...

Futurity recently published insight co-authored by Rena Conti, Associate Professor in the Department of Markets, Public Policy and Law, on...

FactCheck recently published insight from Rena Conti, Associate Professor in the Department of Markets, Public Policy and Law, on the...

Diagnostic care health applications, enabled by artificial intelligence (AI), have become more widely available directly to consumers, including on mobile...

What impact will telemedicine and digital technology have on the U.S. healthcare system? Will telemedicine continue to be popular after...

A recent survey conducted over social media by Abraham (Avi) Seidmann, Everett W. Lord Distinguished Faculty Scholar and Professor of...

Many hospitals are struggling during COVID as they've had to shut down other wings to keep COVID patients safe. Do...

A new survey of more than 6,500 U.S. blood cancer patients and survivors reveals only half are likely to get...

As pharmaceutical companies and politicians scramble to disseminate the COVID-19 vaccine, one thing has become clear – accessibility is not...

The nation’s leading experts in biopharmaceutical innovation and pricing reform recently convened for a virtual discussion exploring the relationship between...

What impact has the pandemic had on the current US health insurance system? What bottlenecks/constraints have there been to care,...

Pfizer and Moderna are working rapidly to roll out the COVID-19 vaccine. Insights@Questrom spoke with Marcus Bellamy, Assistant Professor, Operations...

A new study suggests that up to a third of "excess deaths" in 2020 may not be attributable directly to...

Initial results for the Pfizer vaccine suggest that the vaccine is 95% effective. Eric Jacquier, clinical professor of finance, explains...

In this Q&A, Questrom Magazine talks with Jonathan Woodson and Anita Tucker about improving healthcare coverage, fixing supply issues, and...

In a new piece in Psychology Today, organizational psychologist and Questrom Professor Bill Kahn dives into what that stress means,...

New research from BU Questrom's Rena Conti delves into the Affordable Care Act's effect on prescription drugs and what might...

Smokers’ cravings for cigarettes are strong on their own, but work by Questrom and Harvard researchers suggests one emotion can...

Even though medical AI can perform with expert-level accuracy and deliver cost-effective care at scale, why do patients overwhelmingly prefer...